Loading clinical trials...
Loading clinical trials...
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott
NCT06853314 · HIV Infections, Alcohol Use Disorder, and more
NCT06868641 · HIV Infections
NCT05633056 · Multi Drug Resistant Tuberculosis, HIV Infections
NCT06694753 · HIV Infections
NCT07559266 · HIV Infections, Mental Health, and more
Univ of Arizona / Health Science Ctr
Tucson, Arizona
California Med Research Group
Fresno, California
HIV Research Group
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions